Voloridge Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,343,260
| Closed | -$90.1M | – | 1230 |
|
|
2024
Q3 | $90.1M | Buy |
+1,343,260
| New | +$90.1M | 0.33% | 64 |
|
|
2024
Q2 | – | Sell |
-56,027
| Closed | -$7.77M | – | 1240 |
|
|
2024
Q1 | $7.77M | Buy |
+56,027
| New | +$7.77M | 0.03% | 546 |
|
|
2023
Q3 | – | Sell |
-9,732
| Closed | -$1.25M | – | 1440 |
|
|
2023
Q2 | $1.25M | Sell |
9,732
-71,922
| -88% | -$9.24M | 0.01% | 1077 |
|
|
2023
Q1 | $9.49M | Buy |
+81,654
| New | +$9.49M | 0.05% | 466 |
|
|
2022
Q1 | – | Sell |
-509,176
| Closed | -$68.4M | – | 1443 |
|
|
2021
Q4 | $68.4M | Buy |
509,176
+69,760
| +16% | +$9.36M | 0.37% | 38 |
|
|
2021
Q3 | $60.1M | Buy |
439,416
+327,800
| +294% | +$44.8M | 0.39% | 37 |
|
|
2021
Q2 | $11.9M | Buy |
111,616
+106,540
| +2,099% | +$11.4M | 0.08% | 347 |
|
|
2021
Q1 | $456K | Sell |
5,076
-115,064
| -96% | -$10.3M | ﹤0.01% | 1199 |
|
|
2020
Q4 | $11.1M | Buy |
+120,140
| New | +$11.1M | 0.09% | 252 |
|
|
2020
Q2 | – | Sell |
-68,008
| Closed | -$4.58M | – | 1313 |
|
|
2020
Q1 | $4.58M | Sell |
68,008
-98,848
| -59% | -$6.65M | 0.13% | 176 |
|
|
2019
Q4 | $9.13M | Buy |
+166,856
| New | +$9.13M | 0.18% | 147 |
|
|
2019
Q3 | – | Sell |
-254,248
| Closed | -$9.52M | – | 1097 |
|
|
2019
Q2 | $9.52M | Buy |
254,248
+178,804
| +237% | +$6.7M | 0.26% | 80 |
|
|
2019
Q1 | $2.25M | Buy |
+75,444
| New | +$2.25M | 0.07% | 271 |
|
|
2015
Q4 | – | Sell |
-102,500
| Closed | -$2.2M | – | 216 |
|
|
2015
Q3 | $2.2M | Buy |
+102,500
| New | +$2.2M | 0.1% | 171 |
|